coa tirzepatide — Research Grade | AQRO Research Tirzepatide | Phase 1 Peptides

Pancreatitis risk, though rare (0.1-0.5% in post-market data), requires vigilance throughout treatment

Who Has a Higher Risk for Thrombosis While on GLP-1 Therapy Risk factors that raise the baseline chance of clotting include: Prior DVT or PE Known thrombophilia Active cancer Recent major surgery Prolonged immobilization Estrogen therapy Pregnancy Advanced age Tobacco use Severe dehydration and sudden immobility also raise clot risk during rapid weight change

Disclaimer This article is for informational and educational purposes only

Your diabetes care team will consider your HbA1c targets, cardiovascular risk profile, renal function, and personal preferences when recommending alternatives

Alpha Lipoic Acid with 250ml NS or D5W Benefits: Supports skin rejuvenation, promotes anti-aging effects, replenishes essential nutrients, boosts antioxidant defenses, improves hydration and cellular health

Please verify with the individual plan sponsors for coverage and updated information